WHO ethical criteria for medicinal drug promotion: draft resolution proposed by the delegations of Australia, Belgium, Botswana, Cameroon, Canada, Chile, Denmark, Finland, Ghana, Guatemala, Iceland, Kenya, Lesotho，Lithuania, Mexico, New Zealand, Niger, Norway, Spain, Sweden, Switzerland, Thailand, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania and United States of America
Author(s)
World Health Assembly, 47Keywords
Pharmaceutical productsPharmaceutical Preparations
Drug Industry
Marketing
Ethics, Pharmacy
Health Planning
Health Policy
World Health Organization
ethics
Full record
Show full item recordOnline Access
http://www.who.int/iris/handle/10665/177057Abstract
(Agenda item 19)Date
2015-06-24Type
Governing body documentsIdentifier
oai:apps.who.int:10665/177057A47/A/Conf.Paper No.2
A47/A/Conf.Paper No.2 Rev.1
A47/A/Conf.Paper No.2 Rev.2
http://www.who.int/iris/handle/10665/177057